Loading Events

« All Events

AD/PD Webinar: Recognising Primary Tauopathies

December 2 @ 3:00 pm - 4:00 pm

AD/PD Education on Unlock logo with a bright blue brain illustration to the right of bold text.

Progressive supranuclear palsy, corticobasal degeneration and MAPT-related frontotemporal lobar degeneration are often missed or misdiagnosed. In this live AD/PD™ expert panel, Prof Günter Höglinger and Dr Anne-Marie Wills explore how to recognise primary tauopathies earlier and more accurately.

The panel will cover clinical red flags, atypical presentations, diagnostic approaches including imaging and biomarkers, the conditions that mimic PSP and CBD, and referral pathways, with practical insights for clinical practice. For background on the biology behind these diseases, read Are tauopathies caused by neuronal and glial senescence?, or hear more about FTD research in our ISTAART Relay podcast on frontotemporal dementia.

Agenda

Times as published by AD/PD™ (Central European Time).

  • 16:05–16:15 Primary Tauopathies: Clinical Recognition & Challenges | Prof. Günter Höglinger
  • 16:15–16:25 Diagnostic Pathways, Imaging & Biomarkers | Prof. Günter Höglinger
  • 16:25–16:35 Differential Diagnosis: PSP & CBD Mimics | Dr. Anne-Marie Wills
  • 16:35–16:45 Clinical & Biomarker Features for Diagnostic Accuracy | Dr. Anne-Marie Wills
  • 16:45–17:00 Closing Remarks & Q&A | Dr. Samuel Lockhart

Speakers

Prof Günter Höglinger is Director of the Department of Neurology at Ludwig-Maximilians-Universität (LMU) Munich, a Senior Scientist at DZNE and a Principal Investigator at the SyNergy Cluster of Excellence. His research focuses on alpha-synuclein and tau-related conditions including frontotemporal dementia, PSP and CBD, and he is a leading expert in imaging and fluid biomarkers and clinical trial design.

Dr Anne-Marie Wills is an Associate Professor of Neurology and Director of the CurePSP Center of Care at Massachusetts General Hospital and Harvard Medical School. She specialises in movement disorders such as PSP, CBD and Parkinson’s disease, and leads the CurePSP Genetics Program.

The session is moderated by Dr Sam Lockhart, Senior Scientific Director at Perceptive and Adjunct Associate Professor at Wake Forest School of Medicine.

An application has been made to the UEMS-EACCME® for CME accreditation for this event. The event is intended for medical professionals only, and is supported by an educational grant from Novartis.

Wednesday 2 December 2026, 3pm UK time, online via Zoom. Register in advance using the button below.


Register

submit an event